SSL-VQ:用于在各种疾病中半监督预测治疗点的向量量子化变异自编码器
Satoko Namba1,2, Chen Li1,2, Noriko Yuyama Otani1,2
1Department of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, Kawazu, Iizuka, Fukuoka, 820-8502, Japan.
Bioinformatics (Oxford, England)
|January 29, 2025
概括
这项研究引入了一种新的机器学习方法,使用多式向量量子化变异自编码器 (VQ-VAEs) 来预测疾病的治疗目标,包括罕见的和未表征的疾病. 该方法通过识别新的药物标和适应症来增强药物发现,即使以前的关联是未知的.
科学领域:
- 计算生物学是一种计算生物学.
- 机器学习是机器学习.
- 药物发现 药物发现
背景情况:
- 确定有效的治疗点至关重要,但具有挑战性,特别是对于缺乏已知的点的疾病.
- 未表征的疾病和蛋白质在药物发现管道中存在重大障碍.
研究的目的:
- 开发和验证一种新的机器学习方法,用于在各种疾病中预测治疗点分子.
- 通过结合未表征的疾病和蛋白质的数据来解决已知的有限的治疗目标疾病关联的挑战.
主要方法:
- 在半监督学习 (SSL) 框架内使用多式向量量子化变量自编码器 (VQ-VAEs).
- 综合疾病特异性和蛋白质扰动概况,在转录组层面上提供遗传数据.
- 雇佣跨细胞和跨疾病表示学习从多式联络数据中提取信息特征.
主要成果:
- 成功预测了79种疾病的治疗目标,证明了目标重新定位和新目标/适应症预测的有效性.
- 该模型通过利用疾病和患者特定特征之间的一致性来有效处理未表征的疾病和蛋白质.
- 在各种疾病情景中识别新型治疗点和适应症方面取得了强的表现.
结论:
- 开发的SSL-VQ-VAE方法为识别治疗点提供了强大的工具,显著推进了对特征和非特征疾病的药物发现.
- 预计这种方法将加速对罕见和难以治疗疾病的新疗法策略的识别.
- 该研究提供了一个有价值的框架,用于利用多式联络数据来预测药物标和适应症.
相关概念视频
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...